We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Crocs
CROX
$6.55B
| $26.6K | ﹤0.01% |
237
| – | – |
|
952
Applovin
APP
$116B
| $26.6K | ﹤0.01% |
1,033
+134
| +15% | +$2.77K |
|
953
Ascendis Pharma A/S
ASND
$16.8B
| $26.5K | ﹤0.01% |
297
-157
| -35% | -$13.7K |
|
954
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
| $26.5K | ﹤0.01% |
275
| – | – |
|
955
Santander
BSBR
$43.5B
| $26.4K | ﹤0.01% |
4,146
+365
| +10% | +$2.13K |
|
956
Liberty Energy
LBRT
$3.25B
| $26.3K | ﹤0.01% |
1,968
-18
| -0.9% | -$233 |
|
957
ESAB
ESAB
$5.71B
| $26.3K | ﹤0.01% |
395
| – | – |
|
958
Loews
L
$23.6B
| $26.1K | ﹤0.01% |
440
-62
| -12% | -$3.59K |
|
959
Mercado Libre
MELI
$92.3B
| $26.1K | ﹤0.01% |
22
| – | – |
|
|
SWAV
960
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $26K | ﹤0.01% |
91
+2
| +2% | +$555 |
|
|
OPI
961
DELISTED
Office Properties Income Trust
OPI
| $25.7K | ﹤0.01% |
3,342
+3,304
| +8,695% | +$25K |
|
962
Newmont
NEM
$119B
| $25.7K | ﹤0.01% |
603
-1,256
| -68% | -$57K |
|
963
Marvell Technology
MRVL
$196B
| $25.6K | ﹤0.01% |
429
+173
| +68% | +$8.41K |
|
|
PGRE
964
DELISTED
Paramount Group
PGRE
| $25.6K | ﹤0.01% |
5,781
+2,823
| +95% | +$12.6K |
|
965
Wendy's
WEN
$1.46B
| $25.6K | ﹤0.01% |
1,177
| – | – |
|
|
CMA
966
DELISTED
Comerica
CMA
| $25.5K | ﹤0.01% |
603
-61
| -9% | -$2.46K |
|
967
Korea Electric Power
KEP
$16B
| $25.5K | ﹤0.01% |
3,294
| – | – |
|
968
NOV
NOV
$7B
| $25.5K | ﹤0.01% |
1,587
+362
| +30% | +$5.9K |
|
969
F5
FFIV
$22.7B
| $25.3K | ﹤0.01% |
173
+61
| +54% | +$8.67K |
|
970
CAE Inc. Common Shares
CAE
$8.74B
| $25.3K | ﹤0.01% |
1,129
| – | – |
|
971
ICL Group
ICL
$6.85B
| $25.2K | ﹤0.01% |
4,590
-1,219
| -21% | -$7.37K |
|
972
MarineMax
HZO
$788M
| $25.1K | ﹤0.01% |
734
| – | – |
|
973
OneMain Financial
OMF
$7.47B
| $25K | ﹤0.01% |
573
+3
| +0.5% | +$117 |
|
974
Autohome
ATHM
$2.62B
| $25K | ﹤0.01% |
858
-2
| -0.2% | -$60 |
|
975
Criteo S.A. Ordinary Shares
CRTO
$923M
| $24.9K | ﹤0.01% |
737
+9
| +1% | +$290 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.